Miltenyi Bioindustry supports all efforts, from pre-clinical to commercial scale, as a full-service provider for the development and manufacturing of lentiviral vectors (LVVs) and cell and gene therapy (CGT) products. As a globally active CDMO (Contract Development and Manufacturing Organization) with over 30 years of extensive know-how, they are helping to shape this rapidly growing arena. They leverage the latest technology platforms to make visions of commercial-scale manufacturing a reality. Miltenyi Bioindustry is a division of Miltenyi Biotec, a pioneering innovator and provider of cell processing and analytical platforms, LVVs, and ancillary materials in this field.